What Is the ADR Reporting Department?

Our ADR Reporting Department serves as a pivotal component in monitoring and evaluating the safety of pharmaceutical products. We provide a structured platform for students and healthcare professionals to report adverse drug reactions, contributing to a comprehensive national pharmacovigilance system.

Why Is ADR Reporting Necessary?

Adverse drug reactions (ADRs) are unintended, harmful responses to medications that can compromise patient safety. By systematically collecting and analyzing ADR data, we aim to:

• Identify and assess new safety signals.
• Evaluate the benefit-risk profile of marketed medications.
• Support regulatory agencies in informed decision-making.
• Enhance public health through informed pharmacovigilance practices.

This proactive approach ensures that the benefits of medications outweigh their risks, safeguarding the health of the Indian population.

Our Aims and Objectives

Guided by the objectives of the Pharmacovigilance Programme of India, our department strives to:

• Monitor ADRs: Detect and report adverse drug reactions within the Indian population.
• Promote Safe Medication Use: Encourage the safe and rational use of medicines through education and awareness.
• Generate Evidence-Based Information: Provide data that supports the safety and efficacy of pharmaceutical products.
• Support Regulatory Decisions: Aid regulatory bodies in making informed decisions regarding drug safety.
• Foster a Reporting Culture: Develop a culture of ADR reporting among healthcare professionals and students.

Through these endeavors, we aim to contribute to the global efforts in ensuring the safety and efficacy of medicines.